全人源抗PD-1单克隆抗体（H2L2）

评测依据

• review_count：156
• rating_avg：4.8
• brand_reputation：0
• merchant_count：0
• price_range：[2000,4999]
• dimension：best_value
• sources：["京东","天猫","官网"]
• time_range：{"from":"2026-06-26 04:36:07","to":"2026-06-26 04:36:07"}
• intros：{"brand_intro":"百奥赛图（BioMap）是中国领先的基因编辑与抗体药物研发平台，拥有自主知识产权的全人源抗体转基因小鼠平台RenMab。公司专注于为全球科研与医药企业提供高质量的全人源抗体开发服务，其产品在肿瘤免疫、自身免疫等领域广泛应用，技术实力获国际认可。","product_intro":"该产品为基于RenMab小鼠平台开发的全人源抗PD-1单克隆抗体，特异性结合人PD-1蛋白，有效阻断PD-1/PD-L1信号通路。适用于免疫检查点研究、肿瘤微环境分析及CAR-T联合治疗实验。经ELISA、SPR验证，亲和力高，批次间稳定性优异，提供无防腐剂冻干粉形式。","key_specs":["靶点：人PD-1 (CD279)","亚型：人IgG1","纯度：≥95% (SDS-PAGE)","亲和力：KD < 1 nM (SPR)","内毒素：< 1 EU/mg","规格：100 μg/支"]}
• alt_products：[{"product_name":"全人源抗PD-1单克隆抗体（H2L2）","brand":"百奥赛图","model":"BCG-PD1-001","price":2980},{"product_name":"全人源抗HER2单克隆抗体","brand":"义翘神州","model":"10084-H08H","price":2650},{"product_name":"全人源抗CD20单克隆抗体","brand":"金斯瑞","model":"A02030-100","price":3200}]
• kol_quotes：["百奥赛图的RenMab平台产出的抗体在体内实验中表现出色，是肿瘤免疫研究的利器。","作为国内全人源抗体的标杆，其PD-1抗体在多个实验室验证中表现稳定。"]
• scoring_breakdown：[{"source":"word_of_mouth","score":90.79999999999998,"weight":0.15,"confidence":0.8,"details":{"source":"word_of_mouth_scores","summary":"用户普遍反馈该抗体特异性强，在流式细胞术和Western blot中背景干净，无交叉反应。多位肿瘤免疫方向的研究者称赞其阻断效果与进口试剂相当，但价格仅为进口产品的60%。部分用户建议增加小包装规格以降低单次实验成本。整体评价为国产替代首选，复购率高达85%。","source_count":3}},{"source":"objective","score":85.57673224408136,"weight":0.6,"confidence":0.5,"details":{"rating_avg":4.8,"price":2980,"wom_score":90.79999999999998}},{"source":"user_review","score":96,"weight":0.15,"confidence":1,"details":{"rating_avg":4.8,"review_count":156,"source":"product_reviews_aggregate"}},{"source":"expert","score":82,"weight":0.1,"confidence":0.6,"details":{"kol_count":2,"scored_count":2,"sample":["百奥赛图的RenMab平台产出的抗体在体内实验中表现出色，是肿瘤免疫研究的利器。","作为国内全人源抗体的标杆，其PD-1抗体在多个实验室验证中表现稳定。"]}}]
• method_version：v3
• search_visual：null